Literature DB >> 32449786

Patient-Oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis.

Makiko Kido-Nakahara1, Takeshi Nakahara, Yumi Yasukochi, Dugarmaa Ulzii, Masutaka Furue.   

Abstract

The Patient-Oriented Eczema Measure (POEM, 0-28 points) is a self-assessed, repeatable measurement tool for measuring atopic dermatitis (AD) severity. How-ever, whether POEM score is influenced by allergic comorbidities and whether POEM's severity banding is applicable in web-based surveys for AD remain unclear. A web-based questionnaire survey was conducted in 329 patients with AD. POEM, self-reported severity of AD, and comorbidity of allergic diseases including asthma, pollen rhinitis, allergic conjunctivitis, and food allergy were assessed. POEM scores were not affected by a history of comorbid allergic diseases. The severity banding for POEM scores on the web-based survey was as follows: clear/almost clear = 0, mild = 1-8, moderate = 9-21, and severe/very severe = 22-28, which was comparable to previous banding. These results suggest that POEM is useful for determining AD severity, even in web-based surveys. Patients with POEM scores above 9 points may be grouped into moderate, severe, and very severe AD.

Entities:  

Keywords:  allergic comorbidity, atopic dermatitis, Patient-Oriented Eczema Measure, self-assessed measurement, web-based survey

Mesh:

Year:  2020        PMID: 32449786      PMCID: PMC9137357          DOI: 10.2340/00015555-3530

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  18 in total

1.  Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Authors:  J R Chalmers; E Simpson; C J Apfelbacher; K S Thomas; L von Kobyletzki; J Schmitt; J A Singh; Å Svensson; H C Williams; K Abuabara; V Aoki; M Ardeleanu; M Awici-Rasmussen; S Barbarot; T L Berents; J Block; A Bragg; T Burton; K K Bjerring Clemmensen; A Creswell-Melville; M Dinesen; A Drucker; L Eckert; C Flohr; M Garg; L A A Gerbens; A L B Graff; J Hanifin; D Heinl; R Humphreys; H A Ishii; Y Kataoka; Y A Leshem; B Marquort; M-A Massuel; S Merhand; H Mizutani; H Murota; D F Murrell; T Nakahara; I Nasr; K Nograles; Y Ohya; I Osterloh; J Pander; C Prinsen; L Purkins; M Ridd; T Sach; M-L A Schuttelaar; S Shindo; J Smirnova; A Sulzer; E Synnøve Gjerde; R Takaoka; H Vestby Talmo; M Tauber; F Torchet; A Volke; C-F Wahlgren; S Weidinger; E Weisshaar; A Wollenberg; K Yamaga; C Y Zhao; P I Spuls
Journal:  Br J Dermatol       Date:  2016-07-19       Impact factor: 9.302

Review 2.  Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.

Authors:  P I Spuls; L A A Gerbens; E Simpson; C J Apfelbacher; J R Chalmers; K S Thomas; C A C Prinsen; L B von Kobyletzki; J A Singh; H C Williams; J Schmitt
Journal:  Br J Dermatol       Date:  2017-03-02       Impact factor: 9.302

Review 3.  Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.

Authors:  L A A Gerbens; C A C Prinsen; J R Chalmers; A M Drucker; L B von Kobyletzki; J Limpens; H Nankervis; Å Svensson; C B Terwee; J Zhang; C J Apfelbacher; P I Spuls
Journal:  Allergy       Date:  2016-07-13       Impact factor: 13.146

4.  Clinical practice guidelines for the management of atopic dermatitis 2018.

Authors:  Norito Katoh; Yukihiro Ohya; Masanori Ikeda; Tamotsu Ebihara; Ichiro Katayama; Hidehisa Saeki; Naoki Shimojo; Akio Tanaka; Takeshi Nakahara; Mizuho Nagao; Michihiro Hide; Yuji Fujita; Takao Fujisawa; Masaki Futamura; Koji Masuda; Hiroyuki Murota; Kiwako Yamamoto-Hanada
Journal:  J Dermatol       Date:  2019-10-09       Impact factor: 4.005

Review 5.  Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.

Authors:  Masutaka Furue; Takahito Chiba; Gaku Tsuji; Dugarmaa Ulzii; Makiko Kido-Nakahara; Takeshi Nakahara; Takafumi Kadono
Journal:  Allergol Int       Date:  2017-01-02       Impact factor: 5.836

6.  Utility of the Pediatric Allergic Disease Quality of Life Questionnaire for childhood eczema.

Authors:  K L Hon; W G G Ng; J S C Kung; N S Cheng; D K K Ng; T F Leung
Journal:  Br J Dermatol       Date:  2019-05-06       Impact factor: 9.302

Review 7.  Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine.

Authors:  Th Bieber
Journal:  Allergy       Date:  2012-10-29       Impact factor: 13.146

8.  Web-based survey attracted age-biased sample with more severe illness than paper-based survey.

Authors:  Atle Klovning; Hogne Sandvik; Steinar Hunskaar
Journal:  J Clin Epidemiol       Date:  2009-02-25       Impact factor: 6.437

9.  Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.

Authors:  C R Charman; A J Venn; J C Ravenscroft; H C Williams
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

10.  Tablet, web-based, or paper questionnaires for measuring anxiety in patients suspected of breast cancer: patients' preferences and quality of collected data.

Authors:  Maarten W Barentsz; Hester Wessels; Paul J van Diest; Ruud M Pijnappel; Cees Haaring; Carmen C van der Pol; Arjen J Witkamp; Maurice A van den Bosch; Helena M Verkooijen
Journal:  J Med Internet Res       Date:  2014-10-31       Impact factor: 5.428

View more
  1 in total

1.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.